Sign In
Buy IART
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Integra LifeSciences (IART) Tops Q4 Earnings and Revenue Estimates
09:02am, Wednesday, 22'nd Feb 2023
Integra (IART) delivered earnings and revenue surprises of 1.08% and 0.05%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Integra LifeSciences (IART) Reports Next Week: Wall Street Expects Earnings Growth
11:17am, Wednesday, 15'th Feb 2023
Integra (IART) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Integra LifeSciences to Host Fourth Quarter 2022 Financial Results Conference Call on February 22, 2023
07:30am, Thursday, 09'th Feb 2023
PRINCETON, N.J., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter 2022 financial r
3 MedTech Stocks Likely to Beat Estimates This Earnings Season
09:02am, Wednesday, 08'th Feb 2023
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EXAS, MDT and IART are poised ahead of their earnings releases.
Why Integra (IART) Could Beat Earnings Estimates Again
01:33pm, Thursday, 26'th Jan 2023
Integra (IART) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Integra LifeSciences to Present at 41st Annual J.P. Morgan Healthcare Conference
05:00pm, Wednesday, 21'st Dec 2022
PRINCETON, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president a
Integra's (IART) SIA Buyout Widens Breast Reconstruction Scope
12:02pm, Tuesday, 13'th Dec 2022
With the acquisition, SIA's DuraSorb's resorbable synthetic technology is expected to strengthen Integra's (IART) plastic and reconstructive surgery portfolio.
Integra LifeSciences: Alpha Opportunity Playing Out, Reaffirm Buy
12:18pm, Friday, 02'nd Dec 2022
The CereLink overhang is largely removed, with Integra LifeSciences actively providing an intermediate solution to customers. Divisional strengths were the highlight in Q3 versus absolute numbers thro
Integra's (IART) Q3 Earnings Top, Gross Margin Declines
01:32pm, Thursday, 27'th Oct 2022
Integra (IART) notices recovery in procedure volumes leading to solid growth across most of its product portfolio in Q3.
Integra LifeSciences Holdings Corporation (IART) Q3 2022 - Earnings Call Transcript
03:19pm, Wednesday, 26'th Oct 2022
Integra LifeSciences Holdings Corporation. (NASDAQ:IART ) Q3 2022 Earnings Conference Call October 26, 2022 8:30 AM ET Company Participants Chris Ward - Senior Director, Investor Relations Jan De Witt
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates
08:17am, Wednesday, 26'th Oct 2022
Integra (IART) delivered earnings and revenue surprises of 19.44% and 1.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Integra LifeSciences to Host Third Quarter 2022 Financial Results Conference Call on October 26, 2022
04:30pm, Friday, 07'th Oct 2022
PRINCETON, N.J., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2022 financial re
Here's Why Investors Should Retain Integra (IART) Stock for Now
01:33pm, Friday, 16'th Sep 2022
Investors are optimistic about Integra's (IART) better-than-expected results and the continued demand for its products.
Integra LifeSciences: Wide Dislocation In Fundamentals Vs. Market Value
05:16am, Tuesday, 13'th Sep 2022
Investors have punished Integra LifeSciences in FY22, most recently following the recall of its CereLink monitors. The market priced in the downside swiftly and with deep effect, helping shares find a
Integra LifeSciences Announces Participation in Upcoming Investor Conferences
12:00pm, Tuesday, 23'rd Aug 2022
PRINCETON, N.J., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in
